CORT- Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated (CORT) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 14 sells. CORT is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.57M | $204.21M | -12,837 | |
| Dir | 1.15M | $91.27M | - | |
| Other | 190.0K | $15.12M | - | |
| Other | 84.0K | $6.68M | -75,000 | |
| Other | 78.6K | $6.26M | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Mokari Atabak | Chief Financial Officer | Sale+OE | 40,000 | $81.15 | $3,245,900.05 | -25.9% | - | - | |
| Jun 1, 2026 | Belanoff Joseph K77 | Chief Executive Officer | Sell | 12,837 | $69.74 | $895,252.38 | -0.5% | - | - | |
| May 27, 2026 | Maduck Sean53 | See Remarks | Sale+OE | 75,000 | $65.59 | $4,918,943.74 | -66.1% | - | - | |
| May 27, 2026 | Lyon Joseph Douglas50 | See Remarks | Sell | 5,000 | $65.00 | $325,000.00 | -44.5% | - | - | |
| Apr 7, 2026 | Guyer William45 | Chief Development Officer | Sale+OE | 20,000 | $40.97 | $819,400.00 | -90.0% | - | - | |
| Mar 17, 2026 | Baker G Leonard Jr | Director | Buy | 100,000 | $33.14 | $3,313,808.72 | +4.6% | +147.4% | - | |
| Mar 4, 2026 | Guyer William45 | Chief Development Officer | Sale+OE | 8,233 | $35.99 | $296,346.01 | -78.7% | +99.4% | - | |
| Feb 3, 2026 | Guyer William45 | Chief Development Officer | Sale+OE | 20,000 | $40.87 | $817,334.00 | -94.2% | +26.3% | - | |
| Jan 6, 2026 | Guyer William45 | Chief Development Officer | Sale+OE | 20,000 | $35.18 | $703,656.00 | -94.2% | +14.2% | - | |
| Dec 2, 2025 | Guyer William45 | Chief Development Officer | Sale+OE | 20,000 | $80.08 | $1,601,526.06 | -86.5% | -55.5% | - |
Page 1Next →